View Cart  

Avanir Sues Impax Over Nuedexta Patent Infringement

A A
Avanir Pharmaceuticals is initiating a second lawsuit against Impax Laboratories, alleging Impax’s ANDA for generic Nuedexta infringes on a new Avanir patent.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00